Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

Similar articles for PubMed (Select 21848880)

1.

Anticoagulating obese patients in the modern era.

Patel JP, Roberts LN, Arya R.

Br J Haematol. 2011 Oct;155(2):137-49. doi: 10.1111/j.1365-2141.2011.08826.x. Epub 2011 Aug 16. Review.

PMID:
21848880
2.

[New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].

Dumont B, Faille D, Ajzenberg N.

Med Sci (Paris). 2011 May;27(5):493-500. doi: 10.1051/medsci/2011275014. Epub 2011 May 25. Review. French.

3.

New directions in anticoagulation.

Alpert JS.

Am J Med. 2012 Mar;125(3):217-8. doi: 10.1016/j.amjmed.2011.11.002. No abstract available.

PMID:
22340912
4.

New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.

Morris TA.

Clin Chest Med. 2010 Dec;31(4):707-18. doi: 10.1016/j.ccm.2010.06.006. Review.

PMID:
21047577
5.

New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.

Tran H, Joseph J, Young L, McRae S, Curnow J, Nandurkar H, Wood P, McLintock C.

Intern Med J. 2014 Jun;44(6):525-36. doi: 10.1111/imj.12448.

PMID:
24946813
6.

Beyond unfractionated heparin and warfarin: current and future advances.

Hirsh J, O'Donnell M, Eikelboom JW.

Circulation. 2007 Jul 31;116(5):552-60. Review. No abstract available.

7.

The novel oral anticoagulants: an update for the interventional radiologist.

Crockett MT, Moynagh MR, Kavanagh EC.

AJR Am J Roentgenol. 2012 Sep;199(3):W376-9. doi: 10.2214/AJR.11.8151. Review.

PMID:
22915429
8.

Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation.

Skjøth F, Larsen TB, Rasmussen LH.

Thromb Haemost. 2012 Sep;108(3):405-6. doi: 10.1160/TH12-06-0438. Epub 2012 Jul 10. No abstract available.

PMID:
22782445
9.

[New clinical perspectives in the management of oral direct anticoagulant agents].

Marco P, Zamorano JL, Chana F, Llau JV.

Med Clin (Barc). 2014 Feb 20;142(4):171-8. doi: 10.1016/j.medcli.2013.05.002. Epub 2013 Jul 16. Review. Spanish. No abstract available.

PMID:
23866969
10.

Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?

Harenberg J, Marx S, Wehling M.

Thromb Haemost. 2012 Sep;108(3):407-9. doi: 10.1160/TH12-07-0463. Epub 2012 Jul 26. No abstract available.

PMID:
22837027
11.

Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.

Kar S, Bhatt DL.

Coron Artery Dis. 2012 Sep;23(6):380-90. doi: 10.1097/MCA.0b013e328356490a. Review.

PMID:
22728913
12.

Disadvantages of VKA and requirements for novel anticoagulants.

Shameem R, Ansell J.

Best Pract Res Clin Haematol. 2013 Jun;26(2):103-14. doi: 10.1016/j.beha.2013.07.009. Epub 2013 Jul 23. Review.

PMID:
23953899
13.

[Clinical management of the new anticoagulants].

Zapata Wainberg G, Ximénez-Carrillo Rico A, Vivancos Mora J.

Neurologia. 2012 Mar;27 Suppl 1:33-8. doi: 10.1016/S0213-4853(12)70006-3. Review. Spanish.

14.

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.

Contractor T, Levin V, Martinez MW, Marchlinski FE.

Postgrad Med. 2013 Jan;125(1):34-44. doi: 10.3810/pgm.2013.01.2622. Review.

PMID:
23391669
15.

[New anticoagulants: dabigatran, rivaroxaban and apixaban].

Vargas Ruiz AG, Ramírez López AN, Medina Viramontes ME.

Gac Med Mex. 2012 May-Jun;148(3):257-64. Review. Spanish.

16.

The new oral anticoagulants in atrial fibrillation: once daily or twice daily?

Renda G, De Caterina R.

Vascul Pharmacol. 2013 Sep-Oct;59(3-4):53-62. doi: 10.1016/j.vph.2013.07.003. Epub 2013 Jul 18. Review.

PMID:
23872195
17.

Novel oral anticoagulation in management of venous thromboembolism, atrial fibrillation, and acute coronary syndrome.

Khemasuwan D, Suramaethakul N.

Clin Appl Thromb Hemost. 2012 Sep;18(5):476-86. doi: 10.1177/1076029612438957. Epub 2012 Mar 2. Review.

PMID:
22387584
18.

[Summary and perspectives. Rivaroxaban].

Albaladejo P.

Ann Fr Anesth Reanim. 2008 Dec;27 Suppl 3:S28-31. doi: 10.1016/S0750-7658(08)75144-X. French.

PMID:
19185785
19.

I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different?

[No authors listed]

Duke Med Health News. 2012 Jan;18(1):8. No abstract available.

PMID:
22324070
20.

New oral anticoagulants after acute coronary syndrome.

Bennaghmouch N, Ten Berg JM.

Best Pract Res Clin Haematol. 2013 Jun;26(2):141-50. doi: 10.1016/j.beha.2013.07.006. Epub 2013 Jul 22. Review.

PMID:
23953902
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk